PHOENIX, AZ--(Marketwire - October 14, 2008) - Ewire -- The United States Pharmacopoeia (USP) recently released a new General Chapter < 797 > providing procedures and requirements for compounding sterile preparations. The standards in USP 797 apply to all people and facilities that prepare "compounding sterile preparations" including pharmacies, health care clinics and hospitals. These requirements include routine biological monitoring of the compounding area, including identification by an appropriately credentialed laboratory of any microorganisms recovered. EMLab P&K is proud to provide analytical lab services, customer support, and the BioCassette, a sampler with design features advantageous for USP 797 compliance.

EMLab P&K carries AIHA EMLAP accreditation for fungal as well as bacterial analysis in labs across the United States. Further, it developed the BioCassette -- a patented sampling device that by design avoids high capital expense and, importantly in the case of USP 797, is less prone to contamination issues during the sampling process.

Belinda Vega, EMLab P&K's President, said, "EMLab P&K is not a newcomer to USP 797. We have been providing these lab services for many years, developed the BioCassette with its intrinsic sampling advantages, and are staying abreast of changes in the USP 797 compliance specifications. With our highly qualified analysts and experience in providing analysis and support for USP 797, we are here to help CSP personnel and facilities who are working on USP 797 compliance requirements."

EMLab P&K is recognized as one of the leading commercial indoor air quality laboratories in North America, specializing in analyzing air and surface samples for mold, bacteria, asbestos and allergens. EMLab P&K has received accreditations from AIHA, A2LA, NVLAP and CA-ELAP. For more information, visit the official website at or call (866) 888-6653.

Contact Information: CONTACT: Cole S. Mackelprang Director of Marketing (858) 268-2762 WEB SITE: